⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of AlgiPharma AS and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
AlgiPharma AS
↗Sandvika, Norway
AlgiPharma AS is a clinical-stage biopharmaceutical company founded in 2006, based in Sandvika, Norway. The company specializes in developing proprietary alginate oligosaccharide technology, which serves as a versatile drug delivery platform for nanoparticles, small and large molecules, and as a standalone active pharmaceutical ingredient (API) for treating respiratory diseases, including cystic fibrosis and COPD.
The company leverages its expertise in mucus rheology and biofilm disruption to address unmet medical needs. AlgiPharma maintains pharmaceutical-scale production capabilities and is supported by an extensive patent portfolio, as well as significant research grants from international programs like Horizon 2020 and the Cystic Fibrosis Foundation.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Respiratory therapeutics / Drug delivery
SIZE & FINANCIALS
Employees:1-50
Founded:2006
Ownership:private
Status:operating
FUNDING
Stage:Grant-funded/Private
Total Raised:$46M+
Investors:Cystic Fibrosis Foundation (CFF), Horizon 2020, Norwegian Research Council, Eurostars, Innovation Norway
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2 (OligoG)
Modalities:Alginate oligosaccharides, Drug conjugates, Delivery platform for biologics/nanoparticles
Active Trials:0
Trial Phases:Phase 1: 1 | Phase 2: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Cystic Fibrosis Foundation, Norwegian University of Science and Technology (NTNU), FMC BioPolymer AS
COMPETITION
Position:Niche Player
Competitors:Vertex Pharmaceuticals, Aridis Pharmaceuticals, Spyryx Biosciences, Verona Pharma, Ionis Pharmaceuticals
LEADERSHIP
Key Executives:
Yngvar Berg - CEO
Yngve Mikkelsen - CMO
Philip Rye - CSO
Board Members:Arne Dessen (Chairman)
LINKS
Website:algipharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with AlgiPharma AS. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.